Landos Biopharma Inc (LABP)
22.21
-0.26
(-1.16%)
USD |
NASDAQ |
May 20, 16:00
22.21
0.00 (0.00%)
After-Hours: 20:00
Landos Biopharma Cash from Operations (Quarterly): -8.498M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.498M |
| December 31, 2023 | -4.969M |
| September 30, 2023 | -2.228M |
| June 30, 2023 | -5.11M |
| March 31, 2023 | -8.17M |
| December 31, 2022 | -3.699M |
| September 30, 2022 | -7.573M |
| June 30, 2022 | -18.00M |
| March 31, 2022 | -16.50M |
| Date | Value |
|---|---|
| December 31, 2021 | -12.06M |
| September 30, 2021 | -11.84M |
| June 30, 2021 | 9.40M |
| March 31, 2021 | -12.56M |
| December 31, 2020 | -8.391M |
| September 30, 2020 | -5.379M |
| June 30, 2020 | -5.824M |
| March 31, 2020 | -3.368M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-18.00M
Minimum
Jun 2022
9.40M
Maximum
Jun 2021
-7.339M
Average
-7.573M
Median
Sep 2022
Cash from Operations (Quarterly) Benchmarks
| AbbVie Inc | 4.04B |
| Fusion Pharmaceuticals Inc | -27.31M |
| Masimo Corp | 45.80M |
| Kinnate Biopharma Inc (DELISTED) | -17.36M |
| Invivyd Inc | -50.21M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -20.80M |
| Free Cash Flow Per Share (Quarterly) | -1.369 |
| Free Cash Flow Yield | -15.09% |